Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.
- Update frequency
- every 7 days
- Average duration
- 49 minutes
- Episodes
- 270
- Years Active
- 2020 - 2025
Maximizing mRNA With Precision Nanosystems' James Taylor, Ph.D.
We love to hear from our listeners. Send us a message.
Dr. James Taylor believes that genomic medicine will prove the most revolutionary thing the life sciences industries have ever seen, and that it…
Foundations Of Flexible Manufacturing With Sarepta Therapeutics' Brian Winstead
We love to hear from our listeners. Send us a message.
Is "flexible manufacturing" just another empty buzz concept concocted by the biopharma equipment marketing community, or does it demonstrate rea…
The CDMO Capacity Crunch With Discovery Labs' Audrey Greenberg and Iovance Biotherapeutics' Sumit Verma
We love to hear from our listeners. Send us a message.
While nary a day goes by without a shovel breaking ground on a new CDMO buildout, biopharmas remain hard-pressed to secure the outsourced manufa…
The Clinical Trials Conundrum with Allan Shaw
We love to hear from our listeners. Send us a message.
The clinical trials status quo is a roadblock. They're slow, they're inefficient, and they're expensive. On this episode of the Business of Biot…
CMC Developability Assessments For Rapid Ph.1 Entry with AltruBio's Gene Lee, Ph.D.
We love to hear from our listeners. Send us a message.
Fresh on the heels of an outstanding talk with AltruBio President & CEO Judy Chou, Ph.D., the company's VP of Technology Development, Gene Lee, …
CDMO With A Pipeline with Forge Biologics President & CEO Dr. Timothy J. Miller
We love to hear from our listeners. Send us a message.
Inspired to develop a treatment for Infantile Krabbe Disease, the founders of Forge Biologics picked a unique but strategic approach to funding …
Building A DNA Delivery System With Poseida Tx CEO Eric Ostertag, M.D., Ph.D.
We love to hear from our listeners. Send us a message.
Eric Ostertag, M.D., Ph.D., wanted to launch a biotech. When University of Pennsylvania department heads said no to a licensing deal for lack of…
From Bayer To Startup Bio With AltruBio's Dr. Judy Chou
We love to hear from our listeners. Send us a message.
Judy Chou, Ph.D. was a big-pharma MVP. She earned her academic stripes in the hallowed halls of Yale, the Max Planck Institute, and Harvard Medi…
Creating Competitive Differentiation With Allan Shaw
We love to hear from our listeners. Send us a message.
The biologic therapy market is crowded, and judging by the recent parade of IPOs, competition for investment, mindshare, talent, and ultimately …
Gene Therapy Manufacturing Advances With Aruvant CTO Dr. Palani Palaniappan
We love to hear from our listeners. Send us a message.
Aruvant Chief Technology Officer Palani Palaniappan, Ph.D. joins the Business of Biotech with special guest Tony Khoury, EVP at Project Farma to…
iNK T-Cell Immuno-oncology For Solid Tumors With Dr. Ian Walters
We love to hear from our listeners. Send us a message.
Dr. Ian Walters' company, Portage Biotech, is focused on addressing the 75% of cancer patients who show no, or limited, response to existing the…
How to Apply For BTD And Win It With Drs. Ira Gupta & Shanthi Ganeshan
We love to hear from our listeners. Send us a message.
Everyone in the business is looking for breakthroughs, but only a select few win breakthrough therapy designation from the FDA. Under the guidan…
Cold Chain Integrity & Sustainability With Celyad Oncology's Thomas Lequertier
We love to hear from our listeners. Send us a message.
Maintaining therapeutic integrity through cryopreservation and super cold supply chains have challenged, and continue to vex, biologics producer…
Peptides & Proteins: Resetting The Immune System With Revolo CEO Jonathan Rigby
We love to hear from our listeners. Send us a message.
Revolo Biotherapeutics has entered phase 2 clinical studies of two molecules for autoimmune or allergic diseases that act to reset the immune sy…
Intranasal Prophylactics For Flu & Coronavirus With Leyden Labs' Koenraad Weidhaup
We love to hear from our listeners. Send us a message.
As Leyden Labs Founder & CEO Koenraad Wiedhaup puts it, we breathe in galaxies of viruses on a daily basis. As those viruses multiply and mutate…
Unpacking the SPAC With Allan Shaw
We love to hear from our listeners. Send us a message.
Special-purpose acquisition companies, or SPACs, are all the rage as start-up financing vehicles go, and they're particularly well-suited for em…
A Vaccine For Type 1 Diabetes With Diamyd Medical's Dr. Ulf Hannelius
We love to hear from our listeners. Send us a message.
As leaders at Diamyd Medical made plans to manufacture clinical supply of therapies aimed at preserving and restoring insulin production in Type…
CAR T Process Automation With Kite Pharma's Charles Calderaro III
We love to hear from our listeners. Send us a message.
Kite Pharma Global Head of Technical Operations Chuck Calderaro joins the Business of Biotech for a conversation on a dichotomy in the CAR T-cel…
Biopharma PR 101 with Matt Middleman, M.D.
We love to hear from our listeners. Send us a message.
When is the appropriate time for a new life sciences company to wind up the PR machine? What's the difference between public and investor relati…
A Scale-Up Story with Solis BioDyne Drs. Kadri Artma and Angela Vaasa
We love to hear from our listeners. Send us a message.
When the pandemic hit, Solis Biodyne found its manufacturing capacity stretched to its limit. In short order, it doubled, and then tripled, its …